Sign in
Taking people in United StatesNo phase

Studying Inflammation and Metabolism After Cardiac Arrest in Adults

Observes blood changes in adults for 7 days after cardiac arrest, and recovery.

Key facts

Who runs it
MaineHealth
Where
Portland, United StatesSee the site
Trial code
Registry title
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
Status
Recruiting
People taking part
400 people, planned
Started
Jan 2016
Expected to end
Jan 2028
Type of study
Observational
Record updated
18 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults in intensive care who are unresponsive after a cardiac arrest and resuscitation. Blood samples are taken over 7 days.

Age
18 years or older
Sex
All sexes
Disease stage
Admitted to the intensive care unit after a cardiac arrest and still unresponsive after resuscitation.

Main reasons for not taking part

  • Moribund or actively dying at the time of evaluation
  • Informed consent cannot be obtained within 24 hours of resuscitation
  • Hemoglobin less than 7.0 g/dL
  • Active high-volume bleeding
  • Requiring a transfusion

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Aged 18 years or older
  • Admitted to the intensive care unit after cardiac arrest episode
  • Unresponsive after resuscitation

Who cannot take part

  • Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion
  • Moribund / actively dying at the time of evaluation
  • Informed consent cannot be obtained within 24 hours of resuscitation

Where in United States

  • Maine Medical CenterPortland, United StatesContact: David B Seder, MDTaking people

About the trial

What the trial wants to find out

This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Immunoinflammatory and Metabolic Responses in Post Cardiac Arrest Syndrome (PCAS)
Plain-language title
Studying Inflammation and Metabolism After Cardiac Arrest in AdultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
18 July 2025